At 4,186 pounds, the new 2024 Maserati GranTurismo Trofeo is effectively the same weight as the previous one we tested way ...

Rochester, N.Y., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Carestream today announced the latest update to its Image Suite V4 Software, MR 11: a series of enhancements to help improve customer confidence and ...

With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the customer experience for health systems, hospitals, independent providers and ...

Damotech will invest $2.4 million in Moberly expansion, creating 50 jobs, and C2N Diagnostics is moving its headquarters to St. Louis. Damotech, leading rack safety solutions provider, will expand in ...

This video covers the issues faced with the Maserati Quattroporte GTS when unexpected problems appear. From engine checks to electrical concerns, we go through the process of identifying faults and ...

Is the 2025 Maserati Grecale Folgore a Good SUV? The all-electric Maserati Grecale Folgore retains the style and cachet of its gas-powered siblings but loses its soul with the switch to electric ...

View post: Mansory G-Class Gets Suicide Doors and 808 HP Because Why Not Maserati made a bold decision with its newest model, the Grecale, offering a luxury performance crossover with a range of ...

Quest Diagnostics completed its acquisition of select assets from Fresenius Medical Care’s laboratory business. As part of the transaction, the Secaucus-based testing provider will now offer ...

The Maserati MC20 is dead. Long live the Maserati MCPura, just unveiled at the Goodwood Festival of Speed. Maserati describes the MCPura as "an evolution of" the MC20, and that's accurate because ...

It probably isn't the most shocking news you've ever read, but apparently, Stellantis is thinking pretty seriously about selling Maserati. The official line is still that Maserati is not for sale, but ...

People are usually skeptical about putting premature technology over human judgment, but more than any other industry, science prevails in healthcare. AI may well still be in its infancy, but its ...

Exploratory biomarker analysis of trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in HER2-low/ultralow, hormone receptor–positive (HR+) metastatic breast cancer (mBC) in ...